Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-11-16

FDA Approved: OLOPATADINE HYDROCHLORIDE — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)

View source ↗

Summary

FDA approved a supplemental application for olopatadine hydrochloride from Padagis Israel Pharmaceuticals Ltd, reflecting changes to an existing product. The ac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OLOPATADINE HYDROCHLORIDE (olopatadine hydrochloride)

Snippet

SUPPL AP for OLOPATADINE HYDROCHLORIDE (OLOPATADINE HYDROCHLORIDE)